A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Prostate Cancer · Radical Prostatectomy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Sumit K. Subudhi, MD, PHD) · sksubudhi@mdanderson.org · 713-792-2830
Contact: Principal Investigator (Sumit K. Subudhi, MD, PHD)

Study leads

Sumit K Subudhi, MD, PHD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Prostate Cancer (Adenocarcinoma) · Prostate Cancer (Post Prostatectomy) · Prostate Cancer Surgery

Abroad (travel likely)Recruiting

Stevenage, United Kingdom

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Metastatic Castration-Resistant Prostate Cancer (mCRPC) · Clear Cell Renal Cell Carcinoma (ccRCC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Phoenix, United States

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hershey, United States

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nantong, China